Furthermore, CAR-CD22 transduced with BaEV-LVs exhibited robust CAR expression on 38.3 ± 23.8% (mean ± SD) of NKAES cells and particularly destroyed the NK-resistant pre-B-ALL-RS4;11 cell line. The gene discussed is CD22; the disease is acute lymphoblastic leukemia.